uniQure N.V. Ordinary Shares vs State Street Technology Select Sector SPDR ETF — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while State Street Technology Select Sector SPDR ETF trades at $188.13 (market cap $129.38B). The key difference: State Street Technology Select Sector SPDR ETF is far larger — about 87.4× uniQure N.V. Ordinary Shares's market cap, and State Street Technology Select Sector SPDR ETF is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and State Street Technology Select Sector SPDR ETF for 50 Days on average.
| QURE | XLK | |
|---|---|---|
Market Cap | $1.48B | $129.38B |
Volume | 2,488,780 | 6,753,008 |
Sector | Health | Sector/Thematic |
52-Week High | $70.59 | $202.00 |
52-Week Low | $9.03 | $127.49 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $728.62M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLK trades at $196.24, down slightly by 0.06% on the day, with a bullish technical signal from moving averages while oscillators remain neutral. The ETF faces concentration concerns despite its tech sector exposure, with recent news highlighting AI-driven opportunities and potential interest rate impacts. Support levels are established at $195 and $194, with resistance at $198 and $199.
The outlook for XLK remains positive given strong AI investment themes and large-cap tech resilience, though risks include Fed rate hike sensitivity and sector concentration. Investor sentiment is mixed, balancing growth potential against macroeconomic headwinds and valuation pressures in the technology sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →